Medexus Pharmaceuticals Inc. (OTCMKTS:PDDPF – Get Free Report) shares dropped 33.5% on Monday . The stock traded as low as $2.11 and last traded at $2.14. Approximately 39,966 shares were traded during mid-day trading, an increase of 818% from the average daily volume of 4,355 shares. The stock had previously closed at $3.22.
Medexus Pharmaceuticals Stock Down 33.5 %
The company’s fifty day moving average is $2.14 and its 200 day moving average is $2.14.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc operates as a pharmaceutical company. It provide healthcare products to Healthcare Professionals and patients and focuses on therapeutic areas of auto-immune disease and pediatrics. The company products include Rasuvo, Metoject and Rupall. Medexus was founded by Sylvain Chretien in January 2008 and is headquartered in Verdun, Canada.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- How to invest in marijuana stocks in 7 steps
- 3 Value Stocks You Can Buy Before They Become Big
- Do ETFs Pay Dividends? What You Need to Know
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
